DDR on DTC: Toviaz vs. Vesicare

Share this article:
DDR on DTC: Toviaz vs. Vesicare
DDR on DTC: Toviaz vs. Vesicare

Many people believe that people are healthier because of Direct-to-Consumer advertising. We know DTC triggers millions of patient-physician dialogues, many of which lead to a life-saving diagnosis and treatment. There are also treatment categories that don't involve life-or-death situations, but still make peoples' lives better. Overactive Bladder (OAB) is one of these.

Two brands are fighting for attention from OAB sufferers: GSK-Astellas's Vesicare and Pfizer's Toviaz. Their DTC approaches couldn't be more different. Vesicare has used its “pipe people” campaign for a few years. The pipe people go to jazz concerts, drive cars and have pipe pets. One Toviaz ad shows a “conversation” (texted on a smartphone) between a frustrated sufferer who has not yet seen a doctor and her bladder, while another has the woman's concerns regarding OAB imposed over a drawing of her brain. Both companies share the same call-to-action (talk to your doctor), but the Toviaz ads reach out to new sufferers more than the Vesicare ads do.

Though the campaigns are distinct, both dehumanize a human condition by using a pipe-land uni­verse and a smartphone conversation with an internal organ. It seems the insight teams at both companies' agencies wanted to avoid the reality of OAB. The problem is, these animated and non-human images may de-link the brands emotionally from the problem they want to solve. We hope this is not the case, and that research has proven to them that patients can empathize with inanimate imagery… at least long enough to call their doctor to ask for help.

Deborah Dick-Rath is SVP, healthcare, at Symphony Advanced Media, dd-rath@symphonyam.com
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric